Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.28), $0.05 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $155.1 million versus the consensus estimate of $143.84 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.